FDA Signals Fresh Safety Review of Infant RSV Treatments Amid Kennedy-Led Vaccine Policy Overhaul
U.S. health regulators have notified senior executives at Merck, Sanofi, and AstraZeneca that their FDA-approved infant RSV antibody treatments will undergo new safety scrutiny—another sign of shifting vaccine and pharmaceutical oversight under Health and Human Services Secretary Robert F. Kennedy Jr. The decision, confirmed by multiple sources and internal documents reviewed by Reuters, follows months […]
Discuss on Nostr!
Nostr Note ID note1j2q6k4k29jwtfrsha576q66n5s96kcwclr3zs566cepanfz7xlxszwq68c Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.